Relay Therapeutics, Inc. (RLAY) Free cash flow 2019–2025
Relay Therapeutics, Inc. (RLAY) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$235.9MFY2025 · since FY2019: -$74.1M → -$235.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$235.9M | +6.1% |
| FY2024 | -$251.1M | +17.5% |
| FY2023 | -$304.4M | -27.6% |
| FY2022 | -$238.6M | -206.3% |
| FY2021 | -$77.9M | +25.4% |
| FY2020 | -$104.4M | -40.9% |
| FY2019 | -$74.1M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice